Lam, Vincent K.
Johns Hopkins University · Johns Hopkins Medicine · Sidney Kimmel Comprehensive Cancer Center
6 papers on CoChatORCID 0000-0002-1319-2588
Most cited papers
- Verified
The genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 1,051
- Verified
Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians
Ng, M. C. Y., Park, K. S., Oh, B., Tam, C. H. T., Cho, Y. M., Shin, H. D., Lam, V. K. L., Ma, R. C. W., So, W. Y., Cho, Y. S., et al. (2008) · Diabetes
Genetic Associations and EpidemiologyDiabetes and associated disorders
Cited by 362
- Verified
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Galan-Cobo, A., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., et al. (2024) · Nature
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 194
- Verified
Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
Hwang, M., Canzoniero, J. V., Rosner, S., Zhang, G., White, J. R., Belcaid, Z., Cherry, C., Balan, A., Pereira, G., Curry, A., et al. (2022) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease Prognosis
Cited by 150
- Verified
Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
Sivapalan, L., Murray, J. C., Canzoniero, J. V., Landon, B., Jackson, J., Scott, S., Lam, V., Levy, B. P., Sausen, M., & Anagnostou, V. (2023) · Journal for ImmunoTherapy of Cancer
Cancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers
Cited by 122
- Verified
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer
Cascone, T., Sepesi, B., Lin, H. Y., Kalhor, N., Parra, E. R., Jiang, M., Godoy, M. C. B., Zhang, J., Fossella, F. V., Tsao, A. S., et al. (2020) · Clinical Cancer Research
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free